SkyPASS
Research payments
$433,077
Through program year 2025, $433,077 in research payments was reported against SkyPASS, across 115 payments, paid by Ascendis Pharma, Inc..
- Paid by
- Ascendis Pharma, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $433,077 | 115 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Maya Lodish Bethesda, MD Named on 12 payments
- Yu Yu Rockland, DE Named on 9 payments
- Joshua Yang Orlando, FL Named on 8 payments
- Patricia Fechner Seattle, WA Named on 7 payments
- Lisa Knight Atlanta, GA Named on 7 payments
- Aristides Maniatis Centennial, CO Named on 7 payments
- Kathryn Woods Portland, OR Named on 6 payments
- Daniel Flynn Boise, ID Named on 6 payments
- Bradley Miller Minneapolis, MN Named on 5 payments
- Lawrence Silverman Newark, NJ Named on 5 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.